Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.435 AUD | -2.25% | +12.99% | +26.09% |
Apr. 24 | Immutep Shows Positive Data in Trial to Treat Squamous Cell Cancers in Head, Neck | MT |
Apr. 24 | Immutep Limited Announces Positive Preliminary Topline Results from TACTI-003 Cohort B | CI |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Other languages